# ImpactLife – FDA Inspection, May 9, 2025

Source: https://www.keypedia.com/records/fda_inspections/impactlife/7e234f5c-6535-4a46-8d14-6bbcd2d0d2ba
Source feed: FDA_Inspections

> FDA inspection 1269513 of ImpactLife, May 09, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269513
- Company Name: ImpactLife
- Inspection Date: 2025-05-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Minneapolis District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1147979 - 2021-07-20

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/impactlife/26c13394-fea4-4a9b-ab74-e8a9feb8915d

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d
